Differential expression of complement proteins and regulatory decay accelerating factor in relation to differentiation of cultured human colon adenocarcinoma cell lines

Gut

Volumn 38, Issue 2, 1996, Pages 248-253

  Bernet Camard, M F ^a   Coconnier, M H ^a   Hudault, S ^a   Servin, A L ^a,b  

^a INSERM   (France)

^b Dept de Microbiologie et d'Immunol ^*  (France)

Author keywords

Decay accelerating factor; Diffusely aandering E coli; Enterocytic differentiation; Human intestinal cells; Inflammatory disorders

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DECAY ACCELERATING FACTOR;

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; COLON CARCINOMA; CONTROLLED STUDY; DIGESTIVE SYSTEM INFLAMMATION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0030024046     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.2.248     Document Type: Article

References (38)

1. Nicholson-Weller A. Decay accelerating factor (CD55). Curr Top Microbiol Immunol 1992; 178: 360-8.
2. Andoh A, Fujiyama Y, Bamba T, Hosoda S. Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J Immunol 1993; 151: 4239-47.
3. Molmenti EP, Ziambaras T, Perlmutter DH. Evidence for an accute phase response in human intestinal epithelial cells. J Biol Chem 1993; 268: 14116-24.
4. Medof ME, Walter EI, Rutgers J, Knoweles DM, Nussenzweig V. Identification of the complement decay-accelerating factor (DAF) on epithelial and glandular cells and in body fluid. J Exp Med 1987; 165: 848-64.
5. Kerneis S, Bilge S, Fourel V, Chauviere G, Coconnier MH, Servin AL. Use of purified F1845 fimbrial adhesin to study localization and expression of receptors for diffusely adhering Escherichia coli (DAEC) during enterocytic differentiation of human colon carcinoma cell lines HT-29 and Caco-2 in culture. Infect Immun 1991; 59: 4013-8.
6. Kernéis S, Gabastou JM, Bernet-Camard MF, Coconnier MH, Nowicki B, Servin AL. Human cultured intestinal cells express attachment sites for uropathogenic Escherichia coli bearing adhesins of the Dr adhesin family. FEMS Microbiol Lett 1994; 119: 27-32.
7. Nowicki B, Moulds J, Hull R, Hull S. A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen. Infect Immun 1988; 56: 1057-60.
8. Nowicki B, Labigne A, Moseley S, Hull R, Hull S, Moulds J. The Dr hemagglutinin, afimbrial adhesins AFA-I, AFA-II and AFA-II, and F1845 fimbriae of uropathogenic and diarrhea-associated Escherichia coli belong to a family of hemagglutinins with the Dr receptor recognition. Infect Immun 1990; 58: 279-81.
9. Nowicki B, Hart A, Coyne KE, Lublin DM, Nowicki S. Short consensus repeat-3 domain of recombinant decayaccelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of cell-cell interaction. J Exp Med 1993; 178: 2115-21.
10. Kedinger M. In: Campbell FC, ed. Small bowel enterocyte, culture and transplantation. Austin: RG Landes, 1994: 1-25.
11. Zweibaum A, Laburthe M, Grasset E, Louvard D. In: Schultz SJ, Field M, Frizell RA, eds. Handbook of Physiology. The Gastrointestinal System. New York: Alan Liss, 1991: 223-52.
12. Louvard D, Kedinger M, Hauri HP. The differentiating intestinal epithelial cell: establishment and maintenance of functions through interactions between cellular structures. Ann Rev Cell Biol 1992; 8: 157-95.
13. Pinto M, Robine-Leon S, Appay MD, Kedinger M, Triadou N, Dussaulx E, et al. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 1983; 47: 323-30.
14. Lesuffleur T, Kornowski A, Augeron C, Dussaulx E, Barbat A, Laboisse A, et al. Increased growth adaptability to 5-fluorouracil and methotrexate of HT-29 subpopulations selected for their commitment to differentiation. Int J Cancer 1991; 49: 731-7.
15. Fogh J, Fogh JM, Orfeo T. One hundred and twenty seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 1977; 59: 221-6.
16. Zweibaum A, Pinto M, Chevalier G, Dussaulx E, Triadou N, Lacroix B, et al. Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J Cell Physiol 1985; 122: 21-9.
17. Dharmsathaphorn K, McRoberts JA, Mandel KG, Tisdale LD, Masui H. A human colonic tumor cell line that maintains vectorial electrolyte transport. Am J Physiol 1984; 246: G204-8.
18. Madara JL, Stafford J, Dharmsathaphorn K, Carlson S. Structural analysis of a human intestinal epithelial cell line. Gastroenterology 1987; 92: 1133-44.
19. Barret KE. Positive and negative regulation of chloride secretion in T84 cells. Am J Physiol 1993; 65: C859-68.
20. Nicholson-Weller A. Deficiencies of the decay accelerating factor (DAF) and the C8-binding protein in paroxysmal nocturnal haemoglobinuria. Bailliéres Clin Immunol Allergy 1988; 2: 477-88.
21. Ichida S, Yuzawa Y, Okada H, Yoshioka I, Matsuo S, Localization of the complement regulatory proteins in the normal human kidney. Kidney Int 1994; 46: 89-96.
22. Matsuo S, Nishikage HG, Yoshida F, Nomura A, Piddlesden SJ, Morgan BP. Role of CD59 in experimental glomerulonephritis in rats. Kidney Int 1994; 46: 191-200.
23. Law SKA, Reid KBM. In: Male D, Rickwood D, eds. Complement. Oxford: IRL Press, 1989: 9-27.
24. Yamakawa M, Yamasa K, Tsuge T, Ohrui H, Ogata T, Dobashi T, et al. Protection of thyroid cancer cells by complement-regulatory factors. Cancer 1994; 73: 2808-17.
25. Brooimans RD, Stegmann AP, Van Dorp WT, Van Der Ark AA, Van Der Woude FJ, Van Es LA, et al. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 1991; 88: 379.
26. Morris KM, Colten HR, Bing DH. A quantitative comparison of its biosynthesis in culture by human epithelial and mesenchymal cells. J Exp Med 1978; 148: 1007-19.
27. Rothman BL, Despins AW, Kreuter DL. Cytokine regulation of C3 and C5 production by the human type II pneumocyte cell line, A549. J Immunol 1990; 145: 592-8.
28. Strunk RC, Eidlen DM, Mason RJ. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest 1988; 81: 1419-26.
29. Gallagher RB, Kelly CP, Neville S, Sheils O, Weir DG, Feighery CF. Complement activation within the coeliac small intestine is localised to Brunner's glands. Gut 1989; 30: 1568-73.
30. Halstensen TS, Mollnes TE, Brandtzaeg P. Persistent complement activation in submucosal blood vessels of active inflammatory bowel disease: immunohistochemical evidence. Gastroenterology 1989; 97: 10-20.
31. Halstensen TS, Hatvum M, Scott S, Fausa O, Brandtzaeg P. Association of subepithelial deposition of activated complement and immunoglobulin G and M response to gluten in celiac disease. Gastroenterology 1992; 102: 751-9.
32. Halstensen TS, Mollnes TE, Garred P, Fausa O, Brandtzaeg P. Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis. Gastroenterology 1990; 98: 1264-71.
33. Ahrenstedt O, Knutson L, Nilsson B, Nilsson-Ekdahl K, Odlind B, Hällgren R. Enhanced local production of complement components in the small intestines of patients with Crohn's disease. N Engl J Med 1990; 322: 1345-9.
34. Kangro HO, Chong SKF, Hardiman A, Heath RB, Walker-Smith JA. A prospective study of viral and mycoplasma infections in chronic inflammatory bowel disease. Gastroenterology 1990; 98: 549-53.
35. Burke DA, Axon ATR. Hydrophobic adhesin of E coli in ulcerative colitis. Gut 1988; 29: 41-3.
36. Bilge SS, Apostol Jr JM, Fullner KJ, Moseley SL. Transcriptional organization of the F1845 fimbrial adhesin determinant of Escherichia coli. Mol Microbiol 1993; 7: 993-1006.
37. Nowicki B, Holthofer H, Saraneva T, Rhen M, Väisänen-Rhen V, Korhonen TK. Location of adhesion sites for P-fimbriated and O75X-positive Escherichia coli in the human kidney. Microb Pathog 1986; 1: 109-80.
38. Nowicki B, Truong L, Moulds J, Hull R. Presence of Dr receptor in normal human tissues and its possible role in the pathogenesis of ascending urinary tract infection. Am J Pathol 1988; 133: 1-4.